[ Price : $8.95]
The HHS Office of Inspector General says the National Institutes of Health failed to enforce federal requirements that clinical tr...[ Price : $8.95]
Attorney Douglas Farquhar says FDA speakers at a GMP conference indicated that domestic drug facility inspections are back at oper...[ Price : $8.95]
FDA warns Baltimore, MD-based Emergent BioSolutions about repeat CGMP violations in its manufacturing of finished drugs.[ Price : $8.95]
FDA publishes a regional implementation guide for an International Council on Harmonization document on electronic transmission of...[ Price : $8.95]
FDA accepts for review a Roche supplemental BLA for Polivy (polatuzumab vedotin-piiq) in combination with Rituxan (rituximab) plus...[ Price : $8.95]
FDA accepts for priority review an AstraZeneca supplemental NDA for Lynparza (olaparib) in combination with abiraterone and predni...[ Price : $8.95]
Federal Register notice: FDA establishes a docket to solicit comments on the content of Appendix A in the 7/2018 guidance for indu...[ Price : $8.95]
A new drug pricing analysis finds that for drugs launched so far this year, their median pricing ($257,000) is 43% more than the m...